Press release
HDAC Inhibitors Market to Reach USD 12.31 Billion by 2034 Fueled by Oncology Advancements & Epigenetic Drug Innovation
HDAC Inhibitors Market
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73169
Market Summary
The HDAC Inhibitors Market is expanding rapidly with growing adoption of epigenetic therapies targeting histone deacetylases to regulate gene expression. Approved HDAC inhibitors-including vorinostat, romidepsin, belinostat, and panobinostat-are widely used in hematologic malignancies, especially T-cell lymphomas and multiple myeloma.
Meanwhile, next-generation HDAC inhibitors with improved selectivity (HDAC1/2, HDAC6, HDAC8) are advancing through clinical pipelines for solid tumors, neurodegenerative diseases (Alzheimer's, Huntington's), autoimmune disorders, and inflammatory conditions. North America leads due to strong oncology research and approvals, while Asia-Pacific is the fastest-growing region driven by rising cancer incidence and clinical development activity.
Key Takeaways
• 2024 Market Value: USD 5.14 Billion
• 2034 Forecast: USD 12.31 Billion
• CAGR: 9.0% (2025-2034)
• HDAC6-selective & combination therapy approaches gaining rapid traction
• Strong pipeline targeting lymphoma, multiple myeloma, and solid tumors
• Asia-Pacific expanding due to increased clinical trial participation
Explore Full Report here:
https://exactitudeconsultancy.com/reports/73169/hdac-inhibitors-market
Market Drivers
• Rising global cancer burden, especially hematologic malignancies
• Increasing investment in epigenetic drug discovery
• Advancements in selective HDAC inhibitors with better safety profiles
• Growing research on HDAC inhibitors for CNS and autoimmune disorders
• Expanding use of HDAC inhibitors in combination with immunotherapies
Segmentation Snapshot
By Drug Class
• Class I HDAC Inhibitors
• Class II HDAC Inhibitors
• Class III (Sirtuin) Modulators
• Class IV HDAC Inhibitors
• Pan-HDAC Inhibitors
By Application
• Oncology (Largest Share)
• Neurology
• Autoimmune Diseases
• Inflammatory Disorders
• Others
By Route of Administration
• Oral
• Intravenous
• Others
By End User
• Hospitals
• Specialty Cancer Centers
• Research Institutes
By Region
• North America (Largest Market)
• Europe
• Asia-Pacific (Fastest Growing)
• Latin America
• Middle East & Africa
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73169
Recent Developments
• New HDAC6-selective inhibitors demonstrating promising tumor reduction in trials.
• Combination therapies pairing HDAC inhibitors with checkpoint inhibitors entering advanced phases.
• Increasing research into HDAC inhibitors for neurodegenerative diseases.
Expert Quote - Irfan Tamboli, Business Development Executive
"HDAC inhibitors represent a crucial frontier in epigenetic medicine. Their ability to modulate gene expression is unlocking entirely new therapeutic pathways in cancer and beyond."
Conclusion
The HDAC Inhibitors Market is positioned for strong long-term growth as epigenetic therapies expand across oncology, neurology, and inflammatory diseases. Companies developing highly selective, next-generation HDAC inhibitors-especially for combination oncology regimens-will lead future innovations.
This report is also available in the following languages : Japanese (HDAC阻害剤市場), Korean (HDAC 억제제 시장), Chinese (HDAC抑制剂市场), French (Marché des inhibiteurs d'HDAC), German (Markt für HDAC-Inhibitoren), and Italian (Mercato degli inibitori HDAC), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73169
Our More Reports:
Virtual Biopsy Market
https://exactitudeconsultancy.com/reports/73687/virtual-biopsy-market
Sandhoff Disease Market
https://exactitudeconsultancy.com/reports/72045/sandhoff-disease-market
Severe Hypoglycemia Market
https://exactitudeconsultancy.com/reports/72047/severe-hypoglycemia-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HDAC Inhibitors Market to Reach USD 12.31 Billion by 2034 Fueled by Oncology Advancements & Epigenetic Drug Innovation here
News-ID: 4302536 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for HDAC
Key Factor Supporting Global Histone Deacetylase (HDAC) Inhibitors Market Develo …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Histone Deacetylase (HDAC) Inhibitors Market Size By 2025?
The valuation of the histone deacetylase (hdac) inhibitors market has seen considerable expansion lately, projected to advance from $1.23 billion in 2024 to reach $1.32 billion by 2025, reflecting a consistent annual growth rate of 7.6% over…
Rising Neurodegenerative Disorders Drive Growth In HDAC Inhibitors Market: Pivot …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Histone Deacetylase (HDAC) Inhibitors Market Size Growth Forecast: What to Expect by 2025?
The market for histone deacetylase (HDAC) inhibitors has seen substantial growth in the last few years. The market is predicted to expand from a size of $1.23 billion in 2024 to $1.33 billion in 2025, with…
HDAC Inhibitors Market Projected to Grow Significantly Through 2034 | DelveInsig …
The HDAC Inhibitors companies in the market include - Merck & Co., Bristol Myers Squibb, Celgene Corporation, Spectrum Pharmaceuticals, and Syndax Pharmaceuticals, among others.
The HDAC inhibitor market has shown significant growth in recent years, driven by the increasing prevalence of several key indications commonly treated with HDAC inhibitors, growing research in epigenetics, and expanding applications beyond oncology. According to DelveInsight's comprehensive analysis, key pharmaceutical companies, including Merck & Co., Bristol…
Key Trend Reshaping the Histone Deacetylase (HDAC) Inhibitors Market in 2025: Sh …
Which drivers are expected to have the greatest impact on the over the histone deacetylase (hdac) inhibitors market's growth?
The increasing incidence of neurodegenerative diseases is expected to drive the growth of the histone deacetylase (HDAC) inhibitors market. Neurodegenerative disorders, such as Alzheimer's disease, involve the progressive degeneration of neurons, leading to cognitive and motor dysfunction. The rising prevalence of these disorders is due to aging, genetics, and environmental factors. HDAC…
Histone Deacetylase (HDAC) Inhibitors Market 2022 | Detailed Report
The Histone Deacetylase (HDAC) Inhibitors research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market's key players. Furthermore, the report offers insightful market data and information about the…
HDAC Inhibitors Market - Increasing R&D activities for cancer is expected to boo …
Overview
HDAC inhibitors are a kind of anti-cancer drug that works by causing cell cycle arrest, apoptosis, and death in cancer cells through non-epigenetic or epigenetic control. HDAC inhibitors (HDACi) are potential medicines that have already demonstrated promise in oncological applications such as cancer detection, treatment, and prognostic. Vorinostat (Merck & Co. Inc.) is a new medication that is used to treat epidermal T cell lymphoma as it progresses, relapses, or…
